Recent Finacing
Recent Raise
Receptor Life Sciences develops cannabinoid medicines and delivery technologies, including breath-powered dry-powder inhalers and rapid-absorption oral formulations, targeting acute psychiatric and neurological indications such as inhaled CBD (RLS103).
